BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Samiullah S, Bikharam D, Nasreen. Treatment of chronic hepatitis delta virus with peg-interferon and factors that predict sustained viral response. World J Gastroenterol 2012; 18(40): 5793-5798 [PMID: 23155322 DOI: 10.3748/wjg.v18.i40.5793]
URL: https://www.wjgnet.com/1007-9327/full/v18/i40/5793.htm
Number Citing Articles
1
Satya P. Gupta. Studies on Hepatitis Viruses2018; : 67 doi: 10.1016/B978-0-12-813330-9.00004-1
2
T. Heller, Y. Rotman, C. Koh, S. Clark, V. Haynes-Williams, R. Chang, R. McBurney, P. Schmid, J. Albrecht, D. E. Kleiner, M. G. Ghany, T. J. Liang, J. H. Hoofnagle. Long-term therapy of chronic delta hepatitis with peginterferon alfaAlimentary Pharmacology & Therapeutics 2014; 40(1): 93 doi: 10.1111/apt.12788
3
Luan Felipo Botelho-Souza, Mariana Pinheiro Alves Vasconcelos, Alcione de Oliveira dos Santos, Juan Miguel Villalobos Salcedo, Deusilene Souza Vieira. Hepatitis delta: virological and clinical aspectsVirology Journal 2017; 14(1) doi: 10.1186/s12985-017-0845-y
4
Bhavana Tetali, Brianna Kuperus, Nikhilesh Mazumder. Identifying and Screening At-Risk Patients for Hepatitis Delta Virus: A Case ReportCureus 2023;  doi: 10.7759/cureus.33660
5
Gemma Odena, Eva Stein, Ramon Bataller. Complications of Cirrhosis2015; : 71 doi: 10.1007/978-3-319-13614-1_8
6
Ibrahim Halil Bahcecioglu, Abdurrahman Sahin. Treatment of Delta Hepatitis: Today and in the Future - A reviewInfectious Diseases 2017; 49(4): 241 doi: 10.1080/23744235.2016.1271998
7
Mahwish Aftab, Iram Amin, Muhammad Idrees, Amjad Ali, Shazia Rafique, Shagufta Naz. Molecular epidemiology of hepatitis delta and hepatitis B viruses circulating in two major provinces (East and North-West) of PakistanInfection, Genetics and Evolution 2018; 64: 65 doi: 10.1016/j.meegid.2018.06.013
8
Nayantara Orekondy, Eric R. Kallwitz. A Brief Update on the Management of Hepatitis DeltaCurrent Gastroenterology Reports 2018; 20(12) doi: 10.1007/s11894-018-0666-1
9
Giuseppina Brancaccio, Giovanni B. Gaeta. Treatment of chronic hepatitis due to hepatitis B and hepatitis delta virus coinfectionInternational Journal of Antimicrobial Agents 2019; 54(6): 697 doi: 10.1016/j.ijantimicag.2019.09.012
10
Selma El Messaoudi, Ségolène Brichler, Claire Fougerou-Leurent, Emmanuel Gordien, Athenaïs Gerber, Amal Kortebi, Garance Lagadic, Miroslava Subic-Levrero, Sophie Metivier, Stanislas Pol, Anne Minello, Vlad Ratziu, Vincent Leroy, Philippe Mathurin, Laurent Alric, Fatoumata Coulibaly, Jean-Michel Pawlotsky, Fabien Zoulim, Victor de Lédinghen, Jérémie Guedj. Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtideJHEP Reports 2024; 6(8): 101070 doi: 10.1016/j.jhepr.2024.101070
11
Fulya Gunsar. Treatment of delta hepatitisExpert Review of Anti-infective Therapy 2013; 11(5): 489 doi: 10.1586/eri.13.35
12
Ibrahim Halil Bahcecioglu, Murat Ispiroglu, Ulvi Demirel, Mehmet Yalniz. Pegylated Interferon α Therapy in Chronic Delta Hepatitis: A One-Center ExperienceHepatitis Monthly 2015; 15(3) doi: 10.5812/hepatmon.24366